Lista de obras - Nuno Taveira - Dominio Público Uruguay

A Helical Short-Peptide Fusion Inhibitor with Highly Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus

artículo científico publicado en 2016

A Prime-Boost Immunization Strategy with Vaccinia Virus Expressing Novel gp120 Envelope Glycoprotein from a CRF02_AG Isolate Elicits Cross-Clade Tier 2 HIV-1 Neutralizing Antibodies

scientific article published on 07 April 2020

A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support

artículo científico publicado en 2016

A65 Mitochondrial DNA studies of Lisbon immigrants from Portuguese speaking African countries.

artículo científico publicado en 2018

Accidental Father-to-Son HIV-1 Transmission During the Seroconversion Period

article

Amplification of full-length HIV-2 envelope genes.

artículo científico publicado en 1996

An ancestral HIV-2/simian immunodeficiency virus peptide with potent HIV-1 and HIV-2 fusion inhibitor activity

artículo científico publicado en 2013

Antagonism of BST-2/Tetherin Is a Conserved Function of the Env Glycoprotein of Primary HIV-2 Isolates

scientific article published on 28 September 2016

Antiretroviral drug resistance surveillance among treatment-naive human immunodeficiency virus type 1-infected individuals in Angola: evidence for low level of transmitted drug resistance

scientific article published on 11 May 2009

Assessment of the Cavidi ExaVir Load Assay for Monitoring Plasma Viral Load in HIV-2-Infected Patients

artículo científico publicado en 2017

Baseline susceptibility of primary HIV-2 to entry inhibitors

artículo científico publicado en 2012

Clonal expansion across the seas as seen through CPLP-TB database: A joint effort in cataloguing Mycobacterium tuberculosis genetic diversity in Portuguese-speaking countries

article

Construction and characterization of CD4-independent infectious recombinant HIV-2 molecular clones

article

Correction to "Noncovalent PEG Coating of Nanoparticle Drug Carriers Improves the Local Pharmacokinetics of Rectal Anti-HIV Microbicides"

scientific article published on 22 January 2019

Correction: Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women.

artículo científico publicado en 2018

Detection of HIV-1 DNA by polymerase chain reaction incorporation of digoxigenin-11-dUTP and hybridization to immobilized probes

article

Detection of HIV1 proviral DNA by PCR and hybridization with digoxigenin labelled probes

artículo científico publicado en 1992

Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012

artículo científico publicado en 2014

Development of synthetic light-chain antibodies as novel and potent HIV fusion inhibitors

artículo científico publicado en 2016

Development of water-soluble polyanionic carbosilane dendrimers as novel and highly potent topical anti-HIV-2 microbicides.

artículo científico publicado en 2015

Donor-Recipient Identification in Para- and Poly-phyletic Trees Under Alternative HIV-1 Transmission Hypotheses Using Approximate Bayesian Computation.

artículo científico publicado en 2017

Early infant diagnosis of HIV-1 infection in Luanda, Angola, using a new DNA PCR assay and dried blood spots

artículo científico publicado en 2017

Envelope-specific antibody response in HIV-2 infection: C2V3C3-specific IgG response is associated with disease progression

artículo científico publicado en 2008

Epidemic history of hepatitis C virus genotypes and subtypes in Portugal

scientific article published in Scientific Reports

Evaluation of the clinical sensitivities of three viral load assays with plasma samples from a pediatric population predominantly infected with human immunodeficiency virus type 1 subtype G and BG recombinant forms

artículo científico publicado en 2003

Evaluation of the diagnostic performance of the rapid test VIKIA HIV1/2 in a highly complex HIV-1 epidemic

artículo científico publicado en 2011

Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women.

artículo científico publicado en 2018

Evidence for negative selective pressure in HIV-2 evolution in vivo

artículo científico publicado en 2004

Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response

artículo científico publicado en 2013

Evolutionary and Structural Features of the C2, V3 and C3 Envelope Regions Underlying the Differences in HIV-1 and HIV-2 Biology and Infection ⬇️

artículo científico publicado el 20 de enero de 2011

Genetic diversity and drug resistance profiles in HIV type 1- and HIV type 2-infected patients from Cape Verde Islands

artículo científico publicado en 2011

Genetic diversity, transmission dynamics and drug resistance of Mycobacterium tuberculosis in Angola

artículo científico publicado en 2017

Genetic diversity, transmission dynamics, and drug resistance of Mycobacterium tuberculosis in Luanda, Angola

artículo científico publicado en 2016

Genotypic resistance profiles of HIV-2-infected patients from Cape Verde failing first-line antiretroviral therapy

artículo científico publicado en 2020

Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017

artículo científico publicado en 2018

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

artículo científico publicado en 2018

Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Dise

artículo científico publicado en 2018

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

artículo científico publicado en 2018

HIV-1 diversity, transmission dynamics and primary drug resistance in Angola

artículo científico publicado en 2014

HIV-1 genetic diversity and transmitted drug resistance in health care settings in Maputo, Mozambique

artículo científico publicado en 2009

HIV-2 genetic evolution in patients with advanced disease is faster than that in matched HIV-1 patients

artículo científico publicado en 2010

High genetic diversity of human immunodeficiency virus type 1 in Angola

artículo científico publicado en 2005

Highly divergent subtypes and new recombinant forms prevail in the HIV/AIDS epidemic in Angola: new insights into the origins of the AIDS pandemic.

artículo científico publicado en 2008

In vitro evaluation of novel reverse transcriptase inhibitors TAF and OBP-601 against multi-drug resistant primary isolates of HIV-2

artículo científico publicado en 2018

Inhibition of HIV replication through siRNA carried by CXCR4-targeted chimeric nanobody

scientific article published on 22 October 2019

Mapping 123 million neonatal, infant and child deaths between 2000 and 2017

scientific article published on 16 October 2019

Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017

artículo científico publicado en 2018

Memory B-cell depletion is a feature of HIV-2 infection even in the absence of detectable viremia

artículo científico publicado en 2012

Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillance

scientific article published on 13 January 2020

Mitochondrial DNA in human identification: a review

artículo científico publicado en 2019

Molecular characterization of the env gene from a non-syncytium-inducing HIV-2 isolate (HIV-2ALI)

artículo científico publicado en 1994

On the contribution of Angola to the initial spread of HIV-1.

artículo científico publicado en 2016

Origin and epidemiological history of HIV-1 CRF14_BG.

artículo científico publicado en 2011

Outbreak of acute respiratory infection among infants in Lisbon, Portugal, caused by human adenovirus serotype 3 and a new 7/3 recombinant strain

artículo científico publicado en 2010

Perinatally acquired HIV-2 infection diagnosed at 15 and 24 years of age

article

Phylogenetic demonstration of two cases of perinatal human immunodeficiency virus type 2 infection diagnosed in adulthood

artículo científico publicado en 2004

Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A.

artículo científico publicado en 2011

Potency of HIV-2-specific antibodies increase in direct association with loss of memory B cells

artículo científico publicado en 2017

Potent and broadly reactive HIV-2 neutralizing antibodies elicited by a vaccinia virus vector prime-C2V3C3 polypeptide boost immunization strategy

artículo científico publicado en 2010

Predicting the evolution and control of COVID-19 pandemic in Portugal.

artículo científico publicado en 2020

Predictors of attrition and immunological failure in HIV-1 patients on highly active antiretroviral therapy from different healthcare settings in Mozambique.

artículo científico publicado en 2013

Production and characterization of a mouse monoclonal antibody against the Gag p26 protein of human immunodeficiency virus type 2: identification of a new antigenic epitope.

artículo científico publicado en 2001

Rapid clinical progression to AIDS and death in a persistently seronegative HIV-1 infected heterosexual young man

article

Rare HIV-1 Subtype J Genomes and a New H/U/CRF02_AG Recombinant Genome Suggests an Ancient Origin of HIV-1 in Angola

artículo científico publicado en 2016

Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropism

artículo científico publicado en 2012

Seronegative infection and AIDS caused by an A2 subsubtype HIV-1

article

Serum immunoglobulin A (IgA)-mediated immunity in human immunodeficiency virus type 2 (HIV-2) infection

artículo científico publicado en 2003

Spiro-Lactams as Novel Antimicrobial Agents

artículo científico publicado en 2020

Spiro-β-lactam BSS-730A Displays Potent Activity against HIV and Plasmodium

artículo científico publicado en 2021

Spread of yellow fever virus outbreak in Angola and the Democratic Republic of the Congo 2015–16: a modelling study

artículo científico publicado en 2016

Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics

artículo científico publicado en 2007

The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients

artículo científico publicado en 2008

Use of a new dual-antigen enzyme-linked immunosorbent assay to detect and characterize the human antibody response to the human immunodeficiency virus type 2 envelope gp125 and gp36 glycoproteins

artículo científico publicado en 2006

Vertical transmission of HIV-2.

artículo científico publicado en 1997

Lista de obras de Nuno Taveira

A Helical Short-Peptide Fusion Inhibitor with Highly Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus

A Prime-Boost Immunization Strategy with Vaccinia Virus Expressing Novel gp120 Envelope Glycoprotein from a CRF02_AG Isolate Elicits Cross-Clade Tier 2 HIV-1 Neutralizing Antibodies

A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support

A65 Mitochondrial DNA studies of Lisbon immigrants from Portuguese speaking African countries.

Accidental Father-to-Son HIV-1 Transmission During the Seroconversion Period

Amplification of full-length HIV-2 envelope genes.

An ancestral HIV-2/simian immunodeficiency virus peptide with potent HIV-1 and HIV-2 fusion inhibitor activity

Antagonism of BST-2/Tetherin Is a Conserved Function of the Env Glycoprotein of Primary HIV-2 Isolates

Antiretroviral drug resistance surveillance among treatment-naive human immunodeficiency virus type 1-infected individuals in Angola: evidence for low level of transmitted drug resistance

Assessment of the Cavidi ExaVir Load Assay for Monitoring Plasma Viral Load in HIV-2-Infected Patients

Baseline susceptibility of primary HIV-2 to entry inhibitors

Clonal expansion across the seas as seen through CPLP-TB database: A joint effort in cataloguing Mycobacterium tuberculosis genetic diversity in Portuguese-speaking countries

Construction and characterization of CD4-independent infectious recombinant HIV-2 molecular clones

Correction to "Noncovalent PEG Coating of Nanoparticle Drug Carriers Improves the Local Pharmacokinetics of Rectal Anti-HIV Microbicides"

Correction: Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women.

Detection of HIV-1 DNA by polymerase chain reaction incorporation of digoxigenin-11-dUTP and hybridization to immobilized probes

Detection of HIV1 proviral DNA by PCR and hybridization with digoxigenin labelled probes

Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012

Development of synthetic light-chain antibodies as novel and potent HIV fusion inhibitors

Development of water-soluble polyanionic carbosilane dendrimers as novel and highly potent topical anti-HIV-2 microbicides.

Donor-Recipient Identification in Para- and Poly-phyletic Trees Under Alternative HIV-1 Transmission Hypotheses Using Approximate Bayesian Computation.

Early infant diagnosis of HIV-1 infection in Luanda, Angola, using a new DNA PCR assay and dried blood spots

Envelope-specific antibody response in HIV-2 infection: C2V3C3-specific IgG response is associated with disease progression

Epidemic history of hepatitis C virus genotypes and subtypes in Portugal

Evaluation of the clinical sensitivities of three viral load assays with plasma samples from a pediatric population predominantly infected with human immunodeficiency virus type 1 subtype G and BG recombinant forms

Evaluation of the diagnostic performance of the rapid test VIKIA HIV1/2 in a highly complex HIV-1 epidemic

Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women.

Evidence for negative selective pressure in HIV-2 evolution in vivo

Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response

Evolutionary and Structural Features of the C2, V3 and C3 Envelope Regions Underlying the Differences in HIV-1 and HIV-2 Biology and Infection ⬇️

Genetic diversity and drug resistance profiles in HIV type 1- and HIV type 2-infected patients from Cape Verde Islands

Genetic diversity, transmission dynamics and drug resistance of Mycobacterium tuberculosis in Angola

Genetic diversity, transmission dynamics, and drug resistance of Mycobacterium tuberculosis in Luanda, Angola

Genotypic resistance profiles of HIV-2-infected patients from Cape Verde failing first-line antiretroviral therapy

Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Dise

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

HIV-1 diversity, transmission dynamics and primary drug resistance in Angola

HIV-1 genetic diversity and transmitted drug resistance in health care settings in Maputo, Mozambique

HIV-2 genetic evolution in patients with advanced disease is faster than that in matched HIV-1 patients

High genetic diversity of human immunodeficiency virus type 1 in Angola

Highly divergent subtypes and new recombinant forms prevail in the HIV/AIDS epidemic in Angola: new insights into the origins of the AIDS pandemic.

In vitro evaluation of novel reverse transcriptase inhibitors TAF and OBP-601 against multi-drug resistant primary isolates of HIV-2

Inhibition of HIV replication through siRNA carried by CXCR4-targeted chimeric nanobody

Mapping 123 million neonatal, infant and child deaths between 2000 and 2017

Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017

Memory B-cell depletion is a feature of HIV-2 infection even in the absence of detectable viremia

Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillance

Mitochondrial DNA in human identification: a review

Molecular characterization of the env gene from a non-syncytium-inducing HIV-2 isolate (HIV-2ALI)

On the contribution of Angola to the initial spread of HIV-1.

Origin and epidemiological history of HIV-1 CRF14_BG.

Outbreak of acute respiratory infection among infants in Lisbon, Portugal, caused by human adenovirus serotype 3 and a new 7/3 recombinant strain

Perinatally acquired HIV-2 infection diagnosed at 15 and 24 years of age

Phylogenetic demonstration of two cases of perinatal human immunodeficiency virus type 2 infection diagnosed in adulthood

Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A.

Potency of HIV-2-specific antibodies increase in direct association with loss of memory B cells

Potent and broadly reactive HIV-2 neutralizing antibodies elicited by a vaccinia virus vector prime-C2V3C3 polypeptide boost immunization strategy

Predicting the evolution and control of COVID-19 pandemic in Portugal.

Predictors of attrition and immunological failure in HIV-1 patients on highly active antiretroviral therapy from different healthcare settings in Mozambique.

Production and characterization of a mouse monoclonal antibody against the Gag p26 protein of human immunodeficiency virus type 2: identification of a new antigenic epitope.

Rapid clinical progression to AIDS and death in a persistently seronegative HIV-1 infected heterosexual young man

Rare HIV-1 Subtype J Genomes and a New H/U/CRF02_AG Recombinant Genome Suggests an Ancient Origin of HIV-1 in Angola

Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropism

Seronegative infection and AIDS caused by an A2 subsubtype HIV-1

Serum immunoglobulin A (IgA)-mediated immunity in human immunodeficiency virus type 2 (HIV-2) infection

Spiro-Lactams as Novel Antimicrobial Agents

Spiro-β-lactam BSS-730A Displays Potent Activity against HIV and Plasmodium

Spread of yellow fever virus outbreak in Angola and the Democratic Republic of the Congo 2015–16: a modelling study

Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics

The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients

Use of a new dual-antigen enzyme-linked immunosorbent assay to detect and characterize the human antibody response to the human immunodeficiency virus type 2 envelope gp125 and gp36 glycoproteins

Vertical transmission of HIV-2.